Immune Tolerance Network

The Immune Tolerance Network (ITN) is a distinguished collaborative network dedicated to clinical research. Funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, the Immune Tolerance Network is committed to advancing the clinical development of immune tolerance therapies. These therapies aim to reprogram the immune system, effectively halting disease-causing immune responses while preserving the body's ability to fight infections.

ITN focuses on key areas such as asthma and allergy, autoimmune diseases, type 1 diabetes, and solid organ transplantation. Through the development, funding, and execution of clinical trials, the Immune Tolerance Network integrates mechanistic, laboratory-based studies to ensure comprehensive and innovative research. The Immune Tolerance Network plays a crucial role in fostering advancements in immunological treatments and improving patient outcomes.

The Immune Tolerance Network is continually expanding its research capabilities and collaborative efforts to remain at the forefront of immunological advancements. We invite the manager of The Immune Tolerance Network to create a customized and exclusive company showcase and product listing on our platform, to further enhance its visibility and impact within the global research community.